Medical Oncology, Год журнала: 2024, Номер 42(1)
Опубликована: Дек. 6, 2024
Язык: Английский
Medical Oncology, Год журнала: 2024, Номер 42(1)
Опубликована: Дек. 6, 2024
Язык: Английский
Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)
Опубликована: Май 16, 2024
Gastric cancer represents a highly lethal malignancy with an elevated mortality rate among patients, coupled suboptimal postoperative survival prognosis. Nectin-4, overexpressed oncological target for various cancers, has been exploited to create antibody-drug conjugates (ADCs) treat solid tumors. However, there is limited research on Nectin-4 ADCs specifically gastric cancer, and conventional immunoglobulin G (IgG)-based frequently encounter binding site barriers. Based the excellent tumor penetration capabilities inherent in nanobodies (Nbs), we developed Nectin-4-targeting Nb drug (NDCs) treatment of cancer.
Язык: Английский
Процитировано
11International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(11), С. 5888 - 5888
Опубликована: Май 28, 2024
Cyclodextrins (CDs) are cyclic oligosaccharides able to form noncovalent water-soluble complexes useful in many different applications for the solubilization, delivery, and greater bioavailability of hydrophobic drugs. The complexation 5-fluorouracil (5-FU) with natural or synthetic cyclodextrins permits solubilization this poorly soluble anticancer drug. In theoretical work, between β-CD 5-FU investigated using molecular mechanics (MM) dynamics (MD) simulations water. inclusion formed thanks favorable intermolecular interactions 5-FU. Both 1:1 1:2 β-CD/5-FU stoichiometries investigated, providing insight into their interaction geometries stability over time complexes, affect drug's mobility, suggesting a two-step release mechanism: fast more exposed hydrated drug molecule, freedom movement near rims, slow one less-hydrated well-encapsulated confined MD study drugs specific carriers at atomistic level, possible mechanism highlighting role impact concentration on kinetics process A comparison experimental data literature provides further insights.
Язык: Английский
Процитировано
8Pathology - Research and Practice, Год журнала: 2024, Номер 260, С. 155457 - 155457
Опубликована: Июль 6, 2024
Язык: Английский
Процитировано
4Frontiers in Pharmacology, Год журнала: 2024, Номер 15
Опубликована: Дек. 19, 2024
Apigenin (C
Язык: Английский
Процитировано
4Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Фев. 3, 2025
Язык: Английский
Процитировано
0Oxidative Medicine and Cellular Longevity, Год журнала: 2025, Номер 2025(1)
Опубликована: Янв. 1, 2025
Background: The present study reports the protective effect conferred by scavenging mitochondrial oxidative stress (mtOS) in 5-fluorouracil (5-FU)-induced renal injury. Methods: 5-FU toxicity model was created administering (12 mg/kg b.w. intraperitoneally [i.p.], for 4 days) to male BALB/c mice. of mitochondria-targeted antioxidant (MTA), Mito-TEMPO coadministered at a dosage 0.1 i.p., established terms levels/expressions injury markers, histopathological alterations, DNA damage, proinflammatory mtOS, dysfunction, and modulation apoptotic proteins cell death. Results: A significant rise levels serum urea, uric acid, creatinine noted after administration animals. Immunohistochemical ELISA findings demonstrated decrease podocin conversely increase neutrophil gelatinase-associated lipocalin (NGAL) expression challenge. analysis further revealed Bowman's capsule dilation, glomerular condensation, vacuolar degeneration. treatment significantly lowered reversed expressions NGAL normal, restored normal histoarchitecture tissue. Mitochondrial reactive oxygen species (mtROS), mtLPO, activity enzyme complexes, defense status were improved protected group as compared group. Further, decreased 8-OHdG, reduction death, Bax, Bcl-2, caspase-3 group, indicating its against 5-FU-induced Conclusion: approach targeting mtOS using MTA, Mito-TEMPO, may prove safe adjuvant alleviating during chemotherapy.
Язык: Английский
Процитировано
0Nutrients, Год журнала: 2025, Номер 17(9), С. 1595 - 1595
Опубликована: Май 6, 2025
Honey is a natural product which has been used throughout time as food, spice, and medicine. Its therapeutic use its origins in direct empirical observations of various beneficial actions terms anti-infectious, anti-inflammatory, wound-healing effects, to an antiproliferative effect added. In the context malignant transformation, reductions chronic inflammation, antioxidant action, cell cycle arrest, apoptosis activation contribute this effect, achievements attributed mainly polyphenols composition. A multitude vitro studies performed on cultures try elucidate real mechanism(s) that can scientifically explain action. addition, adjuvant association with cytostatic therapy demonstrates promising enhancing cytotoxic but also reducing some adverse effects. Highlighting these allows for further perspectives be opened regarding honey prophylactic purposes, food supplement. Future will support identification effects patients tumors human body whole, moving from complex implications.
Язык: Английский
Процитировано
0Cell Death and Disease, Год журнала: 2025, Номер 16(1)
Опубликована: Май 20, 2025
Язык: Английский
Процитировано
0Molecular Diversity, Год журнала: 2024, Номер 29(1), С. 425 - 437
Опубликована: Июль 19, 2024
Язык: Английский
Процитировано
3International Journal of Biological Macromolecules, Год журнала: 2024, Номер 279, С. 135048 - 135048
Опубликована: Авг. 30, 2024
Язык: Английский
Процитировано
3